BRAF and colorectal carcinoma: Table 4 presents the correlation between BRAF mutations and Wnt2 expression in CRC (p < 0.001). In conclusion, there was a positive correlation between the Wnt2 expression and BRAF-mutated CRC, and Wnt2 may be a potential therapeutic target for BRAF-mutated CRC.